Skip to main content
. 2019 Jan 8;3(1):83–95. doi: 10.1182/bloodadvances.2018026658

Figure 3.

Figure 3.

Kaplan-Meier curves demonstrating survival outcomes at 60 months after allo-HCT. OS (A) and DFS (B) in intermediate-risk and high-risk patients per MIPSS70 classification; OS (C) and DFS (D) in intermediate-risk, high-risk, and VHR patients per MIPSS70+ v2.0 classification. NE, not estimated.